Masimo

About

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products.

Irvine,California,United States
1001 - 5000
http://www.masimo.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $750M
Industries: Biotechnology,Health Care,Manufacturing,Medical Device
Founded date: Jan 1, 1989
Number Of Employee: 1001 - 5000
Operating Status: Active
Stock Symbol: nasdaq:MASI
Legal Name: Masimo Corporation

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products. It provides a patient monitoring solution that incorporates a monitor or circuit board and sensors, including both proprietary single-patient use and reusable sensors and cables. The company also offers Masimo Signal Extraction Technology, which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. In addition, it provides remote-alarm/monitoring solutions and software. The company sells its products to end-users through direct sales force and distributors, as well as to original equipment manufacturers and partners to incorporate into their products. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$0.95B

Masimo has raised a total of $0.95B in funding over 2 rounds. Their latest funding was raised on Aug 15, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 15, 2022	Post-IPO Equity	$750M	1	Politan Capital Management	—	Detail
Aug 26, 2017	Post-IPO Equity	—	1	Robeco	—	Detail
Nov 11, 2016	Grant	$4.95M	1	Bill & Melinda Gates Foundation	—	Detail
Aug 8, 2007	IPO	$202.60M	—	—	—	Detail
Jul 31, 2000	Series Unknown	—	1	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

2

Masimo has made 2 investments. Their most recent investment was on Jan 3, 2018, when StartUp Health raised $19.30M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jan 3, 2018 StartUp Health	Series Unknown	$19.30M	Biotechnology	Yes
Jan 12, 2010 SEDLine	Series Unknown	$3.50M	Health Care	Yes

Investors

Number of Lead Investors

Number of Investors

3

4

Masimo is funded by 4 investors. Politan Capital Management and Robeco are the most recent investors.

Investor Name	Lead Investor	Funding Round
Politan Capital Management	Yes	Post-IPO Equity
Robeco	Yes	Post-IPO Equity
Bill & Melinda Gates Foundation	Yes	Grant
Signatures Capital	—	Series Unknown

Exits

Masimo has had 1 exits. Masimo most notable exits include SEDLine

Date	Company Name	Exit Type	Industry
Jul 13, 2010	SEDLine	M&A	Health Care	Detail

Acquisition

Masimo has acquired 6 organizations. Their most recent acquisition was SEDLine on Jul 13, 2010. They acquired SEDLine for 0.

Date Company Name	Industry	Acquisition Type	Price
Jul 13, 2010 SEDLine	Health Care	acquisition	—	Detail
Mar 12, 2012 Spire Corporation	Biotechnology	acquisition	$ 8.50M	Detail
Jan 14, 2020 NantHealth - Connected Care	Health Care	acquisition	$ 47.25M	Detail
Mar 20, 2020 TNI medical	Biotechnology	acquisition	—	Detail
Nov 2, 2020 Lidco	Health Care	acquisition	£ 31.10M	Detail